These data show that exosomal hsa-miR21-5p participates in the pathogenesis of acromegaly by disturbing the balance between osteoblasts and osteoclasts, leading to abnormal bone growth, independent of the GH/IGF-1 axis and it may become a novel therapeutic target (84). The gene discussed is GH1; the disease is acromegaly.